$HRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HERON THERAPEUTICS, INC. /DE/. Get notifications about new insider transactions in HERON THERAPEUTICS, INC. /DE/ for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 1,000.00 | 10,800 | 10,800,000 | 10,800 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 0.04 | 5,400 | 216 | 5,400 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 1,000.00 | 588,600 | 588,600,000 | 588,600 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 0.04 | 294,300 | 11,772 | 294,300 | |
Feb 22 2011 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Sell | J | 0.00 | 31,088 | 0 | 95,891 | 127 K to 95.9 K (-24.48 %) |
Jul 12 2010 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 0.60 | 46,436 | 27,862 | 46,436 | |
Jul 12 2010 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 0.60 | 103,564 | 62,138 | 103,564 | |
Jul 12 2010 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | A | 0.60 | 96,908 | 58,145 | 96,908 | |
Jul 12 2010 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | A | 0.60 | 53,092 | 31,855 | 53,092 | |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.00 | 95,891 | 0 | 138,841 | 43 K to 138.8 K (+223.26 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | J | 10.00 | 18,750 | 187,500 | 18,750 | |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Grant | A | 0.00 | 95,891 | 0 | 214,683 | 118.8 K to 214.7 K (+80.72 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 95,891 | 0 | 202,072 | 106.2 K to 202.1 K (+90.31 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 0.00 | 95,891 | 0 | 245,092 | 149.2 K to 245.1 K (+64.27 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.00 | 95,891 | 0 | 210,234 | 114.3 K to 210.2 K (+83.86 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 89,908 | 0 | 126,979 | 37.1 K to 127 K (+242.53 %) |
May 26 2010 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 5,983 | 0 | 37,071 | 31.1 K to 37.1 K (+19.25 %) |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 31,088 | 0 | 31,088 | 0 to 31.1 K |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Option Exercise | A | 1.93 | 32,332 | 62,401 | 32,332 | |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Option Exercise | A | 1.93 | 217,668 | 420,099 | 217,668 | |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | A | 1.93 | 56,823 | 109,668 | 56,823 | |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | A | 1.93 | 93,177 | 179,832 | 93,177 | |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 1.93 | 150,000 | 289,500 | 150,000 | |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Grant | A | 0.00 | 14,042 | 0 | 118,792 | 104.8 K to 118.8 K (+13.41 %) |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.00 | 14,042 | 0 | 114,343 | 100.3 K to 114.3 K (+14.00 %) |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 14,042 | 0 | 106,181 | 92.1 K to 106.2 K (+15.24 %) |
Feb 19 2010 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 0.00 | 14,042 | 0 | 149,201 | 135.2 K to 149.2 K (+10.39 %) |
Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | P | 0.88 | 1,221,590 | 1,074,999 | 1,221,590 | |
Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | P | 0.97 | 1,586,481 | 1,535,714 | 1,586,481 | |
Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 0.88 | 2,443,181 | 2,149,999 | 10,436,506 | 8 M to 10.4 M (+30.57 %) |
Jul 08 2009 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Sell | D | 0.90 | 22,556 | 20,300 | 40,539 | 63.1 K to 40.5 K (-35.75 %) |
Jul 08 2009 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Grant | A | 0.00 | 63,095 | 0 | 63,095 | 0 to 63.1 K |
May 29 2009 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 70,000 | 0 | 92,139 | 22.1 K to 92.1 K (+316.18 %) |
May 29 2009 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Grant | A | 0.00 | 70,000 | 0 | 104,750 | 34.8 K to 104.8 K (+201.44 %) |
May 29 2009 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 0.00 | 70,000 | 0 | 135,159 | 65.2 K to 135.2 K (+107.43 %) |
May 29 2009 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.00 | 70,000 | 0 | 100,301 | 30.3 K to 100.3 K (+231.02 %) |
Feb 25 2009 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | A | 0.61 | 350,000 | 213,500 | 350,000 | |
Jan 20 2009 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 0.71 | 160,000 | 113,600 | 160,000 | |
Jan 05 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.42 | 175,000 | 72,625 | 7,993,325 | 7.8 M to 8 M (+2.24 %) |
Dec 22 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.48 | 415,300 | 200,673 | 7,818,325 | 7.4 M to 7.8 M (+5.61 %) |
Nov 17 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.48 | 775,032 | 372,015 | 7,403,025 | 6.6 M to 7.4 M (+11.69 %) |
Nov 17 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.50 | 66,000 | 32,710 | 6,627,993 | 6.6 M to 6.6 M (+1.01 %) |
Nov 12 2008 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Sell | S | 0.51 | 40,000 | 20,524 | 0 | 40 K to 0 (-100.00 %) |
Nov 12 2008 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Sell | S | 0.51 | 6,881 | 3,531 | 30,301 | 37.2 K to 30.3 K (-18.51 %) |
Oct 14 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.74 | 870,000 | 647,019 | 6,225,693 | 5.4 M to 6.2 M (+16.24 %) |
Nov 04 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.61 | 336,300 | 204,067 | 6,561,993 | 6.2 M to 6.6 M (+5.40 %) |
Oct 02 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.97 | 650,000 | 627,900 | 5,355,693 | 4.7 M to 5.4 M (+13.81 %) |
Oct 01 2008 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | CFO | Option Exercise | A | 1.54 | 50,000 | 77,000 | 50,000 | |
Aug 06 2008 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Buy | P | 1.42 | 1,200 | 1,704 | 1,860 | 660 to 1.9 K (+181.82 %) |
Aug 06 2008 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Buy | P | 1.43 | 660 | 944 | 660 | 0 to 660 |
Aug 06 2008 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Buy | P | 1.47 | 5,000 | 7,350 | 5,000 | 0 to 5 K |
Jul 09 2008 | HRTX | HERON THERAPEUTICS ... | PRENTKI RONALD J | President & CEO | Option Exercise | A | 1.19 | 1,400,000 | 1,666,000 | 1,400,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | CEO, President & In ... | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | CEO, President & In ... | Grant | A | 0.01 | 9,000 | 90 | 65,159 | 56.2 K to 65.2 K (+16.03 %) |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.01 | 9,000 | 90 | 22,139 | 13.1 K to 22.1 K (+68.50 %) |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | TAYLOR ARTHUR T | Director | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | TAYLOR ARTHUR T | Director | Grant | A | 0.01 | 9,000 | 90 | 12,000 | 3 K to 12 K (+300.00 %) |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.01 | 9,000 | 90 | 37,182 | 28.2 K to 37.2 K (+31.94 %) |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 0.01 | 9,000 | 90 | 9,000 | 0 to 9 K |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 1.68 | 12,000 | 20,160 | 12,000 | |
May 30 2008 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Grant | A | 0.01 | 9,000 | 90 | 34,750 | 25.8 K to 34.8 K (+34.95 %) |
Apr 29 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 5,236 | 5,236 | 4,705,693 | 4.7 M to 4.7 M (+0.11 %) |
Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 10,160 | 10,160 | 4,700,457 | 4.7 M to 4.7 M (+0.22 %) |
Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 300 | 300 | 4,690,297 | 4.7 M to 4.7 M (+0.01 %) |
Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 25,625 | 25,617 | 4,689,997 | 4.7 M to 4.7 M (+0.55 %) |
Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 40,000 | 40,000 | 4,664,372 | 4.6 M to 4.7 M (+0.86 %) |
Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 619,987 | 619,987 | 4,624,372 | 4 M to 4.6 M (+15.48 %) |
Jan 23 2008 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President, CEO & D ... | Option Exercise | A | 1.54 | 100,000 | 154,000 | 100,000 | |
Jan 17 2008 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Grant | A | 0.01 | 18,250 | 183 | 18,250 | 0 to 18.3 K |
Jan 17 2008 | HRTX | HERON THERAPEUTICS ... | Retzios Anastassios D. | VP of Clinical Deve ... | Option Exercise | A | 1.37 | 41,708 | 57,140 | 41,708 | |
Jan 17 2008 | HRTX | HERON THERAPEUTICS ... | Retzios Anastassios D. | VP of Clinical Deve ... | Option Exercise | A | 1.37 | 72,992 | 99,999 | 72,992 | |
Jan 17 2008 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Sr VP of R & D | Option Exercise | A | 1.37 | 117,008 | 160,301 | 117,008 | |
Jan 17 2008 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Sr VP of R & D | Option Exercise | A | 1.37 | 72,992 | 99,999 | 72,992 | |
Dec 27 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.44 | 5,000 | 7,200 | 56,159 | 51.2 K to 56.2 K (+9.77 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.70 | 1,200 | 2,040 | 51,159 | 50 K to 51.2 K (+2.40 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.69 | 2,000 | 3,380 | 49,959 | 48 K to 50 K (+4.17 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.68 | 4,000 | 6,720 | 47,959 | 44 K to 48 K (+9.10 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.65 | 900 | 1,485 | 43,959 | 43.1 K to 44 K (+2.09 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.64 | 100 | 164 | 43,059 | 43 K to 43.1 K (+0.23 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.65 | 3,925 | 6,476 | 42,959 | 39 K to 43 K (+10.06 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.64 | 3,020 | 4,953 | 39,034 | 36 K to 39 K (+8.39 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.63 | 1,971 | 3,213 | 36,014 | 34 K to 36 K (+5.79 %) |
Nov 29 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President & CEO | Buy | P | 1.62 | 29 | 47 | 34,043 | 34 K to 34 K (+0.09 %) |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.01 | 12,000 | 120 | 52,558 | 40.6 K to 52.6 K (+29.59 %) |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President, CEO and ... | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President, CEO and ... | Grant | A | 0.01 | 12,000 | 120 | 136,057 | 124.1 K to 136.1 K (+9.67 %) |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | TAYLOR ARTHUR T | Director | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 25 2007 | HRTX | HERON THERAPEUTICS ... | TAYLOR ARTHUR T | Director | Grant | A | 0.01 | 12,000 | 120 | 12,000 | 0 to 12 K |
May 24 2007 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 24 2007 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.01 | 12,000 | 120 | 112,731 | 100.7 K to 112.7 K (+11.91 %) |
May 24 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 24 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 0.01 | 12,000 | 120 | 36,270 | 24.3 K to 36.3 K (+49.44 %) |
Mar 30 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | P | 1.28 | 15,000 | 19,167 | 179,332 | 164.3 K to 179.3 K (+9.13 %) |
Jan 17 2007 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 1.28 | 35,000 | 44,800 | 35,000 | |
Dec 18 2006 | HRTX | HERON THERAPEUTICS ... | WHITEFORD STEPHEN | V.P., Finance & CFO | Grant | A | 0.01 | 15,000 | 150 | 15,000 | 0 to 15 K |
Nov 22 2006 | HRTX | HERON THERAPEUTICS ... | Retzios Anastassios D. | V.P. of Clinical De ... | Option Exercise | A | 1.10 | 75,000 | 82,500 | 75,000 | |
Oct 10 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | President, CEO and ... | Option Exercise | A | 1.15 | 65,000 | 74,750 | 65,000 | |
Aug 15 2006 | HRTX | HERON THERAPEUTICS ... | TAYLOR ARTHUR T | Director | Option Exercise | J | 0.89 | 25,000 | 22,250 | 25,000 | |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.75 | 1,714 | 3,000 | 40,558 | 38.8 K to 40.6 K (+4.41 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.75 | 2,000 | 3,500 | 69,544 | 67.5 K to 69.5 K (+2.96 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.75 | 2,000 | 3,500 | 124,057 | 122.1 K to 124.1 K (+1.64 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.75 | 2,000 | 3,500 | 100,731 | 98.7 K to 100.7 K (+2.03 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,714 | 0 | 164,332 | 162.6 K to 164.3 K (+1.05 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,714 | 0 | 24,270 | 26 K to 24.3 K (-6.60 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.75 | 1,714 | 3,000 | 25,984 | 24.3 K to 26 K (+7.06 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 1,429 | 0 | 83,283 | 81.9 K to 83.3 K (+1.75 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 1,429 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.75 | 1,429 | 2,501 | 1,429 | 0 to 1.4 K |
Jun 29 2006 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Buy | P | 1.50 | 10,000 | 15,000 | 45,000 | 35 K to 45 K (+28.57 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 0.01 | 5,000 | 50 | 67,544 | 62.5 K to 67.5 K (+7.99 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 0.00 | 5,000 | 0 | 38,844 | 33.8 K to 38.8 K (+14.77 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 0.01 | 5,000 | 50 | 122,057 | 117.1 K to 122.1 K (+4.27 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 0.01 | 5,000 | 50 | 98,731 | 93.7 K to 98.7 K (+5.33 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 0.01 | 5,000 | 50 | 24,270 | 19.3 K to 24.3 K (+25.95 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 2.00 | 2,000 | 4,000 | 33,844 | 31.8 K to 33.8 K (+6.28 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 2.00 | 2,500 | 5,000 | 62,544 | 60 K to 62.5 K (+4.16 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 2.00 | 2,750 | 5,500 | 117,057 | 114.3 K to 117.1 K (+2.41 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 2.00 | 2,750 | 5,500 | 93,731 | 91 K to 93.7 K (+3.02 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,250 | 0 | 162,618 | 160.4 K to 162.6 K (+1.40 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,250 | 0 | 19,270 | 21.5 K to 19.3 K (-10.46 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.00 | 2,250 | 4,500 | 21,520 | 19.3 K to 21.5 K (+11.68 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 2,000 | 0 | 81,854 | 79.9 K to 81.9 K (+2.50 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 2,000 | 0 | 0 | 2 K to 0 (-100.00 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 2.00 | 2,000 | 4,000 | 2,000 | 0 to 2 K |
Apr 19 2006 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Buy | J | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Apr 19 2006 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Sell | J | 0.00 | 35,000 | 0 | 30,000 | 65 K to 30 K (-53.85 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.53 | 3,922 | 6,001 | 114,307 | 110.4 K to 114.3 K (+3.55 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.53 | 2,614 | 3,999 | 31,844 | 29.2 K to 31.8 K (+8.94 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.53 | 3,268 | 5,000 | 60,044 | 56.8 K to 60 K (+5.76 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | ROSENBLATT TOBY | Director | Grant | A | 1.53 | 3,595 | 5,500 | 90,981 | 87.4 K to 91 K (+4.11 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,614 | 0 | 160,368 | 157.8 K to 160.4 K (+1.66 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,614 | 0 | 19,270 | 21.9 K to 19.3 K (-11.94 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.53 | 2,614 | 3,999 | 21,884 | 19.3 K to 21.9 K (+13.57 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Buy | J | 0.00 | 3,268 | 0 | 79,854 | 76.6 K to 79.9 K (+4.27 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Sell | J | 0.00 | 3,268 | 0 | 0 | 3.3 K to 0 (-100.00 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | DRURY STEPHEN A | Director | Grant | A | 1.53 | 3,268 | 5,000 | 3,268 | 0 to 3.3 K |
Jan 12 2006 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 1.60 | 35,000 | 56,000 | 35,000 | |
Jan 12 2006 | HRTX | HERON THERAPEUTICS ... | OCONNELL MICHAEL | Chief Executive Off ... | Option Exercise | A | 1.60 | 45,000 | 72,000 | 45,000 | |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | ZERBE ROBERT L MD | Director | Grant | A | 1.74 | 2,299 | 4,000 | 29,230 | 26.9 K to 29.2 K (+8.54 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | WINGER DENNIS L | Director | Grant | A | 1.74 | 2,586 | 4,500 | 56,776 | 54.2 K to 56.8 K (+4.77 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Grant | A | 1.74 | 2,586 | 4,500 | 110,385 | 107.8 K to 110.4 K (+2.40 %) |